B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 5 800 KRW -0.68% Market Closed
Market Cap: ₩357.5B

EV/GP

4.9
Current
40%
Cheaper
vs 3-y average of 8.3

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
4.9
=
Enterprise Value
₩312.8B
/
Gross Profit
₩67B

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
4.9
=
Enterprise Value
₩312.8B
/
Gross Profit
₩67B

Valuation Scenarios

BioPlus Co Ltd is trading below its 3-year average

If EV/GP returns to its 3-Year Average (8.3), the stock would be worth ₩9 671.19 (67% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+80%
Average Upside
43%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 4.9 ₩5 800
0%
3-Year Average 8.3 ₩9 671.19
+67%
5-Year Average 8.9 ₩10 445.39
+80%
Industry Average 5.7 ₩6 675.43
+15%
Country Average 5.4 ₩6 339.56
+9%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close
Market Cap EV/GP P/E
KR
BioPlus Co Ltd
KOSDAQ:099430
356.9B KRW 4.9 22.2
JP
Hoya Corp
TSE:7741
9.9T JPY 11.8 39.6
US
Medline Inc
NASDAQ:MDLN
59.4B USD 0 0
CH
Alcon AG
SIX:ALC
29.2B CHF 6.7 37.2
DK
Coloplast A/S
CSE:COLO B
91B DKK 5.9 23.2
US
Align Technology Inc
NASDAQ:ALGN
13.2B USD 4.4 32.1
UK
ConvaTec Group PLC
LSE:CTEC
4.3B GBP 5.1 32.5
JP
Asahi Intecc Co Ltd
TSE:7747
905.8B JPY 9.5 51.2
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD 3.4 -15.6
KR
HLB Inc
KOSDAQ:028300
8.2T KRW 296.5 -37.2
CN
Intco Medical Technology Co Ltd
SZSE:300677
37.7B CNY 14 22.2
P/E Multiple
Earnings Growth PEG
KR
B
BioPlus Co Ltd
KOSDAQ:099430
Average P/E: 32.5
22.2
42%
0.5
JP
Hoya Corp
TSE:7741
39.6
15%
2.6
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
CH
Alcon AG
SIX:ALC
37.2
32%
1.2
DK
Coloplast A/S
CSE:COLO B
23.2
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
32.1
34%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
32.5
41%
0.8
JP
A
Asahi Intecc Co Ltd
TSE:7747
51.2
40%
1.3
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.6 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -37.2 N/A N/A
CN
Intco Medical Technology Co Ltd
SZSE:300677
22.2
12%
1.8

Market Distribution

In line with most companies in Korea
Percentile
47th
Based on 1 175 companies
47th percentile
4.9
Low
0 — 2.7
Typical Range
2.7 — 10.1
High
10.1 —
Distribution Statistics
Korea
Min 0
30th Percentile 2.7
Median 5.4
70th Percentile 10.1
Max 19 609.2

BioPlus Co Ltd
Glance View

Market Cap
357.5B KRW
Industry
Health Care

BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.

Intrinsic Value
8 354.09 KRW
Undervaluation 31%
Intrinsic Value
Price ₩5 800
B
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett